Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

XLAB vs YMAT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

YMAT Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–1 Matrix Metrics)

YMAT Overall Winner 6-Pillar Tally: XLAB 2 – 3 YMAT (1 Tie) Matrix Metrics: XLAB 1 – 7 YMAT

As of Nov 16, 2026, J-Star Holding Co., Ltd. (YMAT) is the stronger overall head-to-head candidate over XLAB (XLAB) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). XLAB carries a Unified Composite Score of 49.8/100 (HOLD) at $1.96 (N/M Forward P/E, N/A operating margin), whereas YMAT carries 57.8/100 (HOLD) at $0.89 (N/M Forward P/E, -372.2% operating margin).

  • Technical & Structure Timing Caution: XLAB trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile YMAT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 39.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About XLAB vs YMAT
XLAB US Equity
XLAB
Institutional Equity
$1.96
-8.41% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -2.58β · 532% Vol
Unified Composite Score
49.8 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
YMAT NASDAQ Head-to-Head Winner
J-Star Holding Co., Ltd. Ordinary Shares
Sporting & Athletic Goods, Nec
$0.89
-16.02% 1D
Market Cap $4.8M
TTM Revenue $6.1M
Forward P/E N/M
Beta / 30D Vol 5.73β · 218% Vol
Unified Composite Score
57.8 / 100 HOLD
Tech 75.0 Fund 59.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -7.2%), weak momentum, RSI 40
RSI-14: 39.8 · SMA20: $1.58 · SMA50: $1.59

6-Pillar Scorecard Institutional Category Breakdown (XLAB 2 – 3 YMAT)

Columns: Metric · XLAB · YMAT
1. Valuation Multiples YMAT
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.8x
2. Growth & Scale YMAT
Revenue Growth (YoY) N/A -36.1%
Earnings Growth (YoY) N/A -56.4%
TTM Revenue (USD) N/A $6.1M
Market Cap N/A $4.8M
3. Profitability & Quality YMAT
Gross Margin N/A 57.0%
Operating Margin N/A -372.2%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A -275.9%
4. Balance Sheet & Cash Flow XLAB
Cash Generation (TTM) N/A -$22M EBITDA
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE $0.64 Book/Sh · -275.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning XLAB
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: XLAB (1) vs YMAT (7)
Institutional Metric XLAB YMAT Criterion Row Edge
Market Capitalization
Scale
N/A $4.8M Larger Scale YMAT
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A -36.1% Higher Growth YMAT
Operating Margin (TTM)
Profitability
N/A -372.2% Higher Margin YMAT
Net Profit Margin
Profitability
N/A 0.0% Higher Margin YMAT
Return on Equity (ROE)
Capital Efficiency
N/A -275.9% Higher ROE YMAT
52-Week Range Position
Momentum
18% ($1–$7) 15% ($0–$4) Stronger Trend XLAB
Beta / 30D Volatility
Risk Regime
-2.58β · 532% Vol 5.73β · 218% Vol Lower Realized Risk YMAT
Unified Institutional Score
Composite Signal
49.8 / 100 (HOLD) 57.8 / 100 (HOLD) Higher Composite YMAT
Trailing 12M Revenue (USD)
Operating Scale
N/A $6.1M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 57.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$22M EBITDA ($0.64 Book/Sh · -275.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon XLAB +15.45 pp
XLAB: -16.6% · YMAT: -32.05%
3M Horizon YMAT +9.26 pp
XLAB: -61.87% · YMAT: -52.61%
6M Horizon YMAT +9.26 pp
XLAB: -61.87% · YMAT: -52.61%
1Y Horizon YMAT +9.26 pp
XLAB: -61.87% · YMAT: -52.61%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XLAB vs YMAT. Trailing 12-month operating profitability (XLAB N/A vs YMAT -372.2%) and valuation multiples (XLAB N/M vs YMAT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

XLAB ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
YMAT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$6.1M
Gross Margin57.0%
Op. Margin-372.2%
ROE / Fwd P/E-275.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
XLAB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact XLAB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
YMAT BREAKDOWN
83d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact YMAT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
XLAB Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
YMAT Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $4.8M market capitalization and -372.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ XLAB vs YMAT Key Questions & Quantitative Answers

As of Nov 16, 2026, J-Star Holding Co., Ltd. (YMAT) is the stronger overall head-to-head candidate over XLAB (XLAB) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). XLAB carries a Unified Composite Score of 49.8/100 (HOLD) at $1.96 (N/M Forward P/E, N/A operating margin), whereas YMAT carries 57.8/100 (HOLD) at $0.89 (N/M Forward P/E, -372.2% operating margin). Technical & Structure Timing Caution: XLAB trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile YMAT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 39.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

YMAT leads the Growth & Scale pillar: XLAB posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with YMAT at -36.1% YoY revenue growth and -56.4% YoY earnings growth on $6.1M TTM revenue (57.0% gross margin, -372.2% operating margin). On trailing 12-month operating scale, XLAB generates N/A in USD-normalized revenue versus $6.1M for YMAT. In operating R&D and SG&A reinvestment, XLAB deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for YMAT.

YMAT screens cheaper on headline valuation multiples. XLAB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas YMAT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.8x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against XLAB (N/A ROE) versus YMAT (-275.9% ROE) capital efficiency.

In options market volatility and institutional positioning, XLAB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-2.58β · 532% Vol realized risk). By comparison, YMAT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (5.73β · 218% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.